DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) SEC filings, changes and red flags

Red flags

No red flags have been raised by DaVita Inc.’s filings on file.

Filings

Form Period Filed What it reports Flags
10-Q Jun 30, 2026 P1I2: 12 added · 10 removed · 38 modified
P2I1A: no material changes, the filing says
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 4, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 17 added · 23 removed · 83 modified
1A: 47 added · 98 removed · 91 modified
7: 22 added · 39 removed · 63 modified
8-K Feb 2, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 24, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.